
DarioHealth Corp. DRIO
€ 6.73
3.44%
Quartalsbericht 2026-Q1
hinzugefügt 13.05.2026
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
3.98 M |
Marktkapitalisierung |
$ 31.1 M |
EBITDA (LTM) |
$ -34.1 M |
P/E (LTM) |
1.79 |
P/S (LTM) |
1.42 |
EPS (LTM) |
4.53 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 114.95 | 0.14 % | $ 34.9 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 140.28 | -1.58 % | $ 6.56 B | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 4.16 | 12.12 % | $ 5.53 M | Nasdaq Capital Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 20.35 | -0.95 % | $ 590 M | Nasdaq Global Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 17.02 | -2.07 % | $ 515 M | Nasdaq Global Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 118.88 | 0.73 % | $ 14.9 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 21.91 | 1.58 % | $ 1.17 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
ICON Public Limited Company
ICLR
|
$ 115.97 | -0.51 % | $ 9.57 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 145.2 | 0.25 % | $ 23.1 B | Nasdaq Global Select Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.82 | 1.11 % | $ 8.05 M | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 93.87 | -0.64 % | $ 6.34 B | Nasdaq Global Select Market,SPB | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 432.15 | 0.48 % | $ 12.5 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 160.07 | 0.76 % | $ 7.93 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Mettler-Toledo International
MTD
|
$ 1 104.01 | 1.24 % | $ 22.8 B | NYSE,SPB | ||
|
NeoGenomics
NEO
|
$ 9.27 | 1.76 % | $ 1.19 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.97 | -0.37 % | $ 425 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 204.58 | 0.44 % | $ 20.1 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 3.83 | -2.17 % | $ 355 M | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 8.61 | 4.36 % | $ 768 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.1 | -0.18 % | $ 25.7 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 6.43 | 4.38 % | $ 268 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.4 | -1.64 % | $ 5.51 M | Nasdaq Capital Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 60.94 | 3.58 % | $ 3.64 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 260.16 | 1.8 % | $ 21.6 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 447.9 | -0.33 % | $ 169 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.61 | -2.43 % | $ 219 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.09 | 2.54 % | $ 1.97 B | Nasdaq Global Select Market,SPB | ||
|
Waters Corporation
WAT
|
$ 341.99 | 0.34 % | $ 20.4 B | NYSE,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 195.52 | 0.88 % | $ 21.7 B | NYSE,SPB |